Robert Doebele - 07 Jan 2022 Form 4 Insider Report for Rain Therapeutics Inc.

Role
EVP, Chief Scientific Officer
Signature
/s/ Nelson Cabatuan, Attorney-in-fact for Robert Doebele
Issuer symbol
N/A
Transactions as of
07 Jan 2022
Net transactions value
$0
Form type
4
Filing time
04 Feb 2022, 15:35:13 UTC
Next filing
04 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAIN Stock Option (Right to Buy) Award $0 +72,000 $0.000000 72,000 07 Jan 2022 Common Stock 72,000 $12.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 72,000 shares of the Issuer's common stock, one quarter of which will vest on January 7, 2023, with the remaining three quarters vesting in equal monthly installments through January 7, 2026, subject to the Reporting Person's continued service to the Issuer.